Tobias J D, Pratt C B, Parham D M, Green A A, Rao B
Orthopedics. 1985 Jan;8(1):49-52. doi: 10.3928/0147-7447-19850101-08.
The presence of lymph node metastases from osteosarcoma was rare at diagnosis, occurring in only four of 176 patients (2.3%) at St. Jude Children's Research Hospital. An additional patient presented with calcified lymph nodes, which were demonstrated to contain no evidence of metastatic osteosarcoma. These patients did not differ in race, sex or age at diagnosis from other osteosarcoma patients. Each of the four patients with lymph node metastases of osteosarcoma had tumors composed predominantly of the osteoblastic type. Regional nodal metastases, whether alone or in conjunction with other metastatic disease were a poor prognostic factor. Despite aggressive therapy, median survival was 8 1/2 months from diagnosis, which did not differ significantly from the survival achieved by other osteosarcoma patients who had other hematogenous metastases.
骨肉瘤出现淋巴结转移在诊断时较为罕见,在圣裘德儿童研究医院的176例患者中仅有4例(2.3%)出现。另有1例患者有钙化淋巴结,经证实无骨肉瘤转移迹象。这些患者在诊断时的种族、性别或年龄与其他骨肉瘤患者并无差异。4例骨肉瘤淋巴结转移患者的肿瘤均主要为成骨细胞型。区域淋巴结转移,无论单独存在还是与其他转移性疾病并存,都是不良预后因素。尽管进行了积极治疗,但从诊断起的中位生存期为8个半月,与有其他血行转移的其他骨肉瘤患者的生存期相比,差异无统计学意义。